Many AML-associated mutations, including NPM1, TET2 and SMC1A, were detectable in the residual HSC, but others, such as FLT3-ITD and IDH1, were not, indicating that these were probably late events. This evidence concerns the gene NPM1 and acute myeloid leukemia.